Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;220(8):472-479.
doi: 10.1016/j.rce.2020.05.013. Epub 2020 Jun 5.

Monitoring of COVID-19 patients by telemedicine with telemonitoring

[Article in English, Spanish]
Collaborators, Affiliations

Monitoring of COVID-19 patients by telemedicine with telemonitoring

[Article in English, Spanish]
M Martínez-García et al. Rev Clin Esp (Barc). 2020 Nov.

Abstract

Aim: To asses if telemedicine with telemonitoring is a clinically useful and secure tool in the tracking of patients with COVID-19.

Methods: A prospective observational study of patients with COVID-19 diagnosis by positive PCR considered high-risk tracked with telemedicine and telemonitoring was conducted in the sanitary area of Lugo between March 17th and April 17th, 2020. Two groups of patients were included: Outpatient Tracing from the beginning and after discharge. Every patient sent a daily clinical questionnaire with temperature and oxygen saturation 3 times a day. Proactive monitoring was done by getting in touch with every patient at least 11a day.

Results: 313 patients (52.4% female) with a total average age of 60.9 (DE 15.9) years were included. Additionally, 2 patients refused to join the program. Since the beginning, 224 were traced outpatient and 89 after being discharged. Among the first category, 38 (16.90%) were referred to Emergency department on 43 occasions; 18 were hospitalized (8.03%), and 2 deceased. Neither deaths nor a matter of vital emergency occurred at home. When including patients after admissions monitoring was done in 304 cases. One patient re-entered (0.32%) to the hospital, and another one left the program (0.32%). The average time of monitoring was 11.64 (SD 3.58) days, and 224 (73.68%) patients were discharged during the 30 days of study.

Conclusions: Our study suggests that telemedicine with home telemonitoring, used proactively, allows for monitoring high-risk patients with COVID-19 in a clinically useful and secure way.

Objetivo: Evaluar si la telemedicina con telemonitorización es una herramienta clínicamente útil y segura para el seguimiento de pacientes con COVID-19.

Métodos: Estudio observacional prospectivo de los pacientes con diagnóstico de COVID-19 por PCR positiva y considerados de alto riesgo que se siguieron con telemedicina y telemonitorización en el Área Sanitaria de Lugo entre el 17 de marzo y el 17 de abril del 2020. Se incluyeron 2 grupos de pacientes: seguimiento ambulatorio desde el inicio y tras el alta hospitalaria. Cada paciente remitió un cuestionario clínico al día con su temperatura y saturación de oxígeno 3 veces al día. El seguimiento fue proactivo, contactando con todos los pacientes al menos una vez al día.

Resultados: Se incluyó a 313 pacientes (52,4% mujeres) con edad media 60,9 (DE 15,9) años. Otros 2 pacientes rehusaron entrar en el programa. Desde el inicio, se siguió ambulatoriamente a 224 pacientes y a 89 pacientes tras su alta hospitalaria. Entre los primeros, 38 (16,90%) se remitieron a Urgencias en 43 ocasiones con 18 (8,03%) ingresos y 2 fallecidos. En los domicilios no hubo fallecimientos ni urgencias vitales. Incluyendo a los pacientes tras hospitalización, el seguimiento se realizó en 304 casos. Un paciente reingresó (0,32%) y otro abandonó (0,32%). El tiempo medio de seguimiento fue 11,64 (DE 3,58) días y en los 30 días del estudio 224 (73,68%) pacientes fueron dados de alta.

Conclusiones: Nuestros datos sugieren que la telemedicina con telemonitorización domiciliaria, utilizada de forma proactiva, permite un seguimiento clínicamente útil y seguro en pacientes con COVID-19 de alto riesgo.

Keywords: COVID-19; COVID-19 management; Case management; Gestión COVID-19; Gestión caso; Telemedicina; Telemedicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient monitoring work flow.
Figure 2
Figure 2
Flow chart of COVID-19 positive adult patients who are considered high-risk and in at-home monitoring (March 17 to April 17, 2020).
Figure 3
Figure 3
Monitoring of COVID-19 patients with telemedicine: probability of continuing in the program over time.

Comment in

  • [Telemedicine for COVID-19].
    Ena J. Ena J. Rev Clin Esp. 2020 Nov;220(8):501-502. doi: 10.1016/j.rce.2020.06.002. Epub 2020 Jun 9. Rev Clin Esp. 2020. PMID: 33994574 Free PMC article. Spanish. No abstract available.

References

    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. - PMC - PubMed
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 doi: 10.1001/jama.2020.2648. - DOI - PubMed
    1. and the Northwell COVID-19 Research Consortium. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W. Presenting characteristics comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052–2059. - PMC - PubMed
    1. Bashshur R., Doarn C.R., Frenk J.M., Kvedar J.C., Woolliscroft J.O. Telemedicine and the COVID-19 pandemic. Lessons for the future. Telemed J E Health. 2020;26:571–573. - PubMed
    1. Young J.D., Abdel-Massih R., Herchline T., McCurdy L., Moyer K.J., Scott J.D. Infectious Diseases Society of America Position Statement on telehealth and telemedicine as applied to the practice of infectious diseases. Clin Infect Dis. 2019;68:1437–1443. - PubMed

LinkOut - more resources